ENTPD1 and COVID-19: We performed a comprehensive analysis of the ex vivo CD39 and CD73 expression pattern on CD4+ T, CD8+ T, natural killer T (NKT) and natural killer (NK) cells of COVID-19 patients using a 16-color flow cytometry panel.